Top Story

Sun Pharma to own Ocular Technologies plus rights to dry eye treatment

October 26, 2016

Sun Pharmaceutical Industries will acquire Ocular Technologies Sarta, or OTS, the owner of the rights to the dry eye disease treatment Seciera, according to a Sun Pharma press release.

Auven Therapeutics, which currently owns OTS, will receive a $40 million upfront payment from Sun Pharma, as well as “contingent developmental milestones and sales milestones,” and tiered royalties based on Seciera sales, the release said.

Wireless visual cortical stimulator successfully activated in first human subject

October 26, 2016
The first successful implantation and activation of a wireless visual cortical stimulator in a human subject has occurred, Second Sight Medical Products announced in a…
Meeting News

Ciliary muscle electrostimulation may delay early presbyopia

October 26, 2016
CHICAGO — Electrostimulation of the ciliary muscle is a noninvasive method to delay early presbyopia in patients between the ages of 40 and 50 years, according to…

BLOG: Ginger vs. Mary Ann

October 26, 2016
Ginger or Mary Ann? Come on. Don’t pretend you don’t know what I’m talking about. If you’re of a certain age, you’ve engaged in hours of…
Meeting NewsVideo

VIDEO: Cyclophotocoagulation effective at reducing IOP, medication burden

October 25, 2016
CHICAGO — At the American Academy of Ophthalmology meeting here, Ahad Mahootchi, MD, discusses the implementation of the Cyclo G6 photocoagulator (Iridex) in his…
More News Headlines »
Clinical Science

Value of Optical Coherence Tomography Angiography Imaging in Diagnosis and Treatment of Hemangioblastomas in von Hippel-Lindau Disease

Ophthalmic Surgery, Lasers and Imaging Retina, October 2016, Volume 47 Issue 10
The introduction of optical coherence tomography angiography (OCTA) provides new insights into the retinal vasculature…
More »

Comparative Treatment Trials for Wet AMD: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Meeting News Coverage

VIDEO: ECP useful in conjunction with cataract surgery

October 22, 2016
More »